Impact Of An Integrated Treatment Algorithm Based on Platelet Function Testing and Clinical Risk Assessment: Results Of The TRIAGE Study


Posted on: Fri 08-05-2015

 
On behalf of the TRIAGE study Investigators TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition
 
SCAI 2015 | San Diego | 8 May 2015
 
• High on treatment platelet reactivity (HTPR) is associated with greater incidence of adverse cardiac events
 
• Platelet function testing alone for thienopyridine selection after PCI has not been shown to correlate with improved outcomes in randomized trials
 
• The role of platelet function testing in the context of clinical risks has not been investigated
  
Download slides for the TRIAGE study presented at #SCAI2015 here  (565kb)
 
Source:
. C. Michael Gibson MD ‏@CMichaelGibson
. Mount Sinai Heart